Medications for Amenorrhea

18 results

  • Bromocriptine mesylate (bromocriptine mesylate)

    (Bromocriptine mesylate)
    Zydus Pharmaceuticals USA Inc.
    Usage: Bromocriptine mesylate capsules are indicated for treating hyperprolactinemia-related disorders (e.g., amenorrhea, infertility, hypogonadism), acromegaly, and symptoms of Parkinson's disease. It may be used with levodopa to enhance efficacy and reduce side effects, especially in patients experiencing tolerance or "end of dose failure."

  • Bromocriptine mesylate (bromocriptine mesylate)

    (Bromocriptine mesylate)
    Sandoz Inc
    Usage: Bromocriptine mesylate tablets are indicated for treating hyperprolactinemia-related dysfunctions (e.g., amenorrhea, infertility), acromegaly, and symptoms of Parkinson's disease. They help reduce tumor size in prolactin-secreting adenomas and enhance effects of levodopa in Parkinson's, while potentially reducing levodopa dosage and adverse reactions.

  • Clomiphene citrate (clomiphene citrate)

    (Clomiphene Citrate)
    NuCare Pharmaceuticals,Inc.
    Usage: Clomiphene citrate is indicated for treating ovulatory dysfunction in women seeking pregnancy, particularly those with conditions like polycystic ovary syndrome. It should be used only after excluding other causes of infertility, and patients should have normal ovarian function and no abnormal vaginal bleeding. Long-term therapy is not recommended.

  • Clomiphene citrate (clomiphene citrate)

    (Clomiphene Citrate)
    Advagen Pharma Ltd
    Usage: Clomiphene citrate is indicated for treating ovulatory dysfunction in women seeking pregnancy. It is effective for conditions like polycystic ovary syndrome and certain amenorrhea cases. Patients must not be pregnant, have ovarian cysts or abnormal bleeding, and should have normal liver function before therapy.

  • Crinone (progesterone)

    (progesterone)
    Columbia Laboratories, Inc.
    Usage: Crinone® 8% is indicated for progesterone supplementation in Assisted Reproductive Technology (ART) for infertile women with progesterone deficiency. Crinone® 4% treats secondary amenorrhea, while Crinone® 8% is for women who have not responded to Crinone® 4%.

  • Hydroxyprogesterone caproate (hydroxyprogesterone caproate)

    (Hydroxyprogesterone Caproate)
    Mylan Institutional LLC
    Usage: Hydroxyprogesterone Caproate Injection is indicated for non-pregnant women to treat advanced adenocarcinoma of the uterine corpus (Stage III or IV), manage amenorrhea and abnormal uterine bleeding due to hormonal imbalances, and as a test for endogenous estrogen production and secretory endometrium development.

  • Medroxyprogesterone acetate (medroxyprogesterone acetate)

    (Medroxyprogesterone Acetate)
    ReadyMeds
    Usage: Medroxyprogesterone Acetate Tablets USP are indicated for treating secondary amenorrhea, abnormal uterine bleeding from hormonal imbalances, and reducing endometrial hyperplasia in nonhysterectomized postmenopausal women taking conjugated estrogens.

  • Medroxyprogesterone acetate (medroxyprogesterone acetate)

    (Medroxyprogesterone Acetate)
    Bryant Ranch Prepack
    Usage: Medroxyprogesterone acetate tablets are indicated for treating secondary amenorrhea, abnormal uterine bleeding from hormonal imbalances, and preventing endometrial hyperplasia in nonhysterectomized postmenopausal women on daily oral conjugated estrogens (0.625 mg).

  • Medroxyprogesterone acetate (medroxyprogesterone acetate)

    (Medroxyprogesterone Acetate)
    Bryant Ranch Prepack
    Usage: Medroxyprogesterone acetate tablets are indicated for treating secondary amenorrhea and abnormal uterine bleeding caused by hormonal imbalance without organic pathology. Additionally, they prevent endometrial hyperplasia in nonhysterectomized postmenopausal women receiving daily oral conjugated estrogens (0.625 mg).

  • Medroxyprogesterone acetate (medroxyprogesterone acetate)

    (Medroxyprogesterone Acetate)
    Denton Pharma, Inc. dba Northwind Pharmaceuticals
    Usage: Medroxyprogesterone Acetate Tablets are indicated for treating secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance. They also help prevent endometrial hyperplasia in nonhysterectomized postmenopausal women on daily oral conjugated estrogens (0.625 mg).